Analyst Research

Report Title Price
Provider: ValuEngine, Inc.
Provider: Finlabo SIM Spa
Provider: Reuters Investment Profile
Provider: Pechala's Reports

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Grifols SA Acquires 60% Stake In Progenika Biopharma SA

Monday, 4 Mar 2013 02:44am EST 

Grifols SA announced that it has acquired shares of Progenika Biopharma SA, representing 60% stake in the company. Total price of the stake amounts to EUR 37 million. Moreover, Grifols SA and shareholders of Progenika Biopharma SA have been reciprocally granted rights to buy and sell shares, representing the remaining 35% of the capital, exercisable within 3 years. 

Company Quote

0.575 +1.50%
11:35am EDT